These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3207084)

  • 1. ABO blood groups and their relationship to transitional cell carcinoma of the urinary bladder in 30 Jordanian patients.
    Murshidi MS
    Acta Urol Belg; 1988; 56(4):517-22. PubMed ID: 3207084
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood group H antigen in transitional carcinoma of the urinary bladder.
    Tichý M; Tichá V; Jansa P; Student V; Vanák J
    Acta Univ Palacki Olomuc Fac Med; 1991; 130():157-62. PubMed ID: 1838863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of blood groups and transitional cell carcinoma of the bladder.
    Kirkali Z; Eryigit M
    Int Urol Nephrol; 1993; 25(3):255-7. PubMed ID: 8225826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of ABH blood group isoantigen and prognosis in patients with transitional cell bladder carcinoma.
    Malmström PU; Busch C; Norlen BJ
    Scand J Urol Nephrol Suppl; 1988; 110():205-11. PubMed ID: 3187409
    [No Abstract]   [Full Text] [Related]  

  • 5. Pathologist's role in bladder cancer.
    Farrow GM
    Semin Oncol; 1979 Jun; 6(2):198-206. PubMed ID: 482961
    [No Abstract]   [Full Text] [Related]  

  • 6. Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion.
    Esrig D; Freeman JA; Elmajian DA; Stein JP; Chen SC; Groshen S; Simoneau A; Skinner EC; Lieskovsky G; Boyd SD; Cote RJ; Skinner DG
    J Urol; 1996 Sep; 156(3):1071-6. PubMed ID: 8709310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 64 patients.
    Montie JE
    J Urol; 2005 Jun; 173(6):1920-1. PubMed ID: 15879778
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of ABO blood type on outcomes in patients with primary nonmuscle invasive bladder cancer.
    Klatte T; Xylinas E; Rieken M; Kluth LA; Rouprêt M; Pycha A; Fajkovic H; Seitz C; Karakiewicz PI; Lotan Y; Babjuk M; de Martino M; Scherr DS; Shariat SF
    J Urol; 2014 May; 191(5):1238-43. PubMed ID: 24333243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CA19.9 and CEA in transitional cell carcinoma of the bladder: serological and immunohistochemical findings.
    Hegele A; Mecklenburg V; Varga Z; Olbert P; Hofmann R; Barth P
    Anticancer Res; 2010 Dec; 30(12):5195-200. PubMed ID: 21187512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of A,B and H blood group antigens in urothelial carcinoma of the urinary bladder].
    Tichý M; Tichá V; Jansa P; Student V; Vanák J
    Cesk Patol; 1991 Mar; 27(1-2):13-9. PubMed ID: 1893425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overstaging of transitional cell carcinoma: clinical significance of lamina propria fat within the urinary bladder.
    Bochner BH; Nichols PW; Skinner DG
    Urology; 1995 Mar; 45(3):528-31. PubMed ID: 7879346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of the blood group antigens A and B in carcinoma of the urinary bladder].
    Tichý M; Jansa P; Student V; Tichá V; Vanák J
    Bratisl Lek Listy; 1992 Aug; 93(8):415-20. PubMed ID: 1464022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of circulating tumour cells in peripheral blood of patients with advanced non-metastatic bladder cancer.
    Rink M; Chun FK; Minner S; Friedrich M; Mauermann O; Heinzer H; Huland H; Fisch M; Pantel K; Riethdorf S
    BJU Int; 2011 May; 107(10):1668-75. PubMed ID: 20735381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Words of wisdom. Re: Impact of ABO blood type on outcomes in patients with primary nonmuscle invasive bladder cancer.
    Ohno Y
    Eur Urol; 2014 Aug; 66(2):391. PubMed ID: 25305789
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunofluorescence study of the distribution of ABH cell surface antigens in bladder tumours (author's transl)].
    Vallancien G; Rouger P; Leclerc JP; Kuss R
    Sem Hop; 1982 May; 58(19):1161-4. PubMed ID: 6285497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of urine cytology with ABO(H) antigenicity in transitional cell carcinoma of the bladder.
    Das G; Glashan RW
    J Clin Pathol; 1988 May; 41(5):538-9. PubMed ID: 3384984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment staging of invasive transitional cell carcinoma of the bladder. American College of Radiology. ACR Appropriateness Criteria.
    Bigongiari LR; Amis ES; Bluth EI; Bush WH; Choyke PL; Fritzsche P; Holder L; Newhouse JH; Sandler CM; Segal AJ; Resnick MI; Rutsky EA
    Radiology; 2000 Jun; 215 Suppl():697-702. PubMed ID: 11037487
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecular staging of bladder cancer with RT-PCR assay for CK20 in peripheral blood, bone marrow and lymph nodes: comparison with standard histological staging.
    Ribal MJ; Mengual L; Marín M; Algaba F; Ars E; Fernández PL; Oliva R; Villavicencio H; Alcaraz A
    Anticancer Res; 2006; 26(1A):411-9. PubMed ID: 16475726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum tumor markers may predict overall and disease specific survival in patients with clinically organ confined invasive bladder cancer.
    Margel D; Tal R; Baniel J
    J Urol; 2007 Dec; 178(6):2297-300; discussion 2300-1. PubMed ID: 17936837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The study of relationship between nuclear metrix protein 22 urinary level and the grade and stage of bladder transitional cell carcinoma].
    Xin DQ; You R; Ding Y; Liu LQ; Na YQ
    Zhonghua Wai Ke Za Zhi; 2006 May; 44(10):681-3. PubMed ID: 16784679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.